Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Shedir Pharma Group Spa | BIT:SHE | Italy | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.00 | - |
From Apr 2022 to Apr 2025
Shedir Pharma Group chiude il primo semestre con un utile netto di 1 mln, in crescita del 45% rispetto agli 0,7 mln dello stesso periodo dello scorso anno.
L'Ebitda, si legge in una nota, è pari a 2,7 mln (+20% a/a), mentre l'Ebit si attesta a 1,6 mln (+51% a/a). La posizione finanziaria netta risulta in miglioramento rispetto al 31 dicembre 2021 attestandosi ad una posizione cash positive di 8,9 mln del 30 giugno 2022.
liv
(END) Dow Jones Newswires
September 29, 2022 10:51 ET (14:51 GMT)
Copyright (c) 2022 MF-Dow Jones News Srl.
1 Year Shedir Pharma Chart |
1 Month Shedir Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
